Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "company"

5717 News Found

Group Mangalam enters India’s wellness market with launch of Neat Everyday
Healthcare | June 09, 2026

Group Mangalam enters India’s wellness market with launch of Neat Everyday

The company has announced its entry into India’s rapidly expanding nutraceuticals and wellness sector with the launch of Neat Everyday, a new consumer wellness brand


AbbVie showcases broad blood cancer pipeline at EHA 2026 with 21 presentations
Clinical Trials | June 09, 2026

AbbVie showcases broad blood cancer pipeline at EHA 2026 with 21 presentations

The company will present 21 oral and poster presentations spanning investigational and approved therapies


Merck appoints Clara Sattler de Sousa e Brito and Robert Machinek to key leadership roles
People | June 09, 2026

Merck appoints Clara Sattler de Sousa e Brito and Robert Machinek to key leadership roles

Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development


FUJIFILM reshapes life sciences leadership to accelerate cell therapy and iPSC expansion
News | June 09, 2026

FUJIFILM reshapes life sciences leadership to accelerate cell therapy and iPSC expansion

Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California


Eli Lilly's oral weight-loss drug shows major fat loss across stages of menopause in trials
Clinical Trials | June 09, 2026

Eli Lilly's oral weight-loss drug shows major fat loss across stages of menopause in trials

The results come from post-hoc analyses of more than 1,500 women enrolled in the Phase 3 ATTAIN-1 and ATTAIN-2 trials, presented at the American Diabetes Association’s 86th Scientific Sessions


AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial
Clinical Trials | June 09, 2026

AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial

At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint


Barentz opens new pharma hub in Pennsylvania to accelerate growth across North America
Supply Chain | June 09, 2026

Barentz opens new pharma hub in Pennsylvania to accelerate growth across North America

New Chesterbrook office strengthens customer engagement, partner collaboration, and regional expansion strategy


Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial
News | June 09, 2026

Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial

Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter


Punita Kumar-Sinha appointed Independent Director at Aurobindo Pharma USA
People | June 09, 2026

Punita Kumar-Sinha appointed Independent Director at Aurobindo Pharma USA

Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors


Medtronic secures CE Mark for Stealth AXiS surgical navigation system in Europe
Medical Device | June 09, 2026

Medtronic secures CE Mark for Stealth AXiS surgical navigation system in Europe

New-generation platform enhances anatomical visualization, streamlines surgical workflows, and expands access to advanced navigation technology for ENT surgeons across Europe